share_log

MariMed Analyst Ratings

Benzinga Analyst Ratings ·  Oct 28, 2022 09:18
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/28/2022 60.38% BTIG → $0.85 Initiates Coverage On → Buy

MariMed Questions & Answers

What is the target price for MariMed (MRMD)?

The latest price target for MariMed (OTCQX: MRMD) was reported by BTIG on October 28, 2022. The analyst firm set a price target for $0.85 expecting MRMD to rise to within 12 months (a possible 60.38% upside). 1 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for MariMed (MRMD)?

The latest analyst rating for MariMed (OTCQX: MRMD) was provided by BTIG, and MariMed initiated their buy rating.

When is the next analyst rating going to be posted or updated for MariMed (MRMD)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MariMed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MariMed was filed on October 28, 2022 so you should expect the next rating to be made available sometime around October 28, 2023.

Is the Analyst Rating MariMed (MRMD) correct?

While ratings are subjective and will change, the latest MariMed (MRMD) rating was a initiated with a price target of $0.00 to $0.85. The current price MariMed (MRMD) is trading at is $0.53, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment